481Case Report: Abscopal effect of radiotherapy in a patient with metastatic duodenal adenocarcinoma and resistance to chemoimmunotherapy.2025 · Europe PMC
482Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype.2025 · Europe PMC
483Clinical factors predictive of tumour cytogenetics and metastasis in 86 patients with choroidal nevus growth into melanoma (DIP and DOT study).2025 · Europe PMC
484Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathway.2025 · Europe PMC
485Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis.2025 · Europe PMC
487High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population.2025 · Europe PMC
489NY-ESO-1 targeting in non-small cell lung cancer: promise and challenges of letetresgene autoleucel.2025 · Europe PMC
491Personalised Approach in Oncology to Improve the Efficiency of Patient Diagnosis and Treatment.2025 · Europe PMC
492<sup>177</sup>Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial.2025 · Europe PMC
493Emerging Anti-Cancer and Repurposed Therapies for Overcoming Multidrug Resistance in Lung Cancer.2025 · Europe PMC
494Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and Sex.2025 · Europe PMC
495Atypical teratoid rhabdoid tumor with extraneural metastases: a case report with genomic analysis.2025 · Europe PMC
496Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineering.2025 · Europe PMC
497Prognostic value of immunohistochemical markers of intratumoral hypoxia in pregnancy-associated breast cancer.2025 · Europe PMC
498Prognostic significance of tumour-infiltrating T lymphocytes in ovarian cancer: a protocol for systematic review and meta-analysis.2025 · Europe PMC
499Contribution of the seric cytokeartin fragment 21.1 (cyf 21.1) as a tumor marker in a population of algerien women with breast cancer undergoing chemotherapy.2025 · Europe PMC
500Salvage cytoreductive surgery and HIPEC in chemoresistant juvenile granulosa cell tumour.2025 · Europe PMC